Cidara Therapeutics Stock Investor Sentiment

CDTX Stock  USD 17.85  1.07  5.66%   
Slightly above 62% of Cidara Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Cidara Therapeutics stock suggests that many investors are alarmed at this time. Cidara Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Cidara Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
over a week ago at news.google.com         
Cidara Therapeutics, Inc. Receives 32.20 Consensus Price Target from Analysts - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Heres Why Cidara Therapeutics, Inc. Is Skyrocketing - MSN
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Cidara Therapeutics, Inc. Sees Large Increase in Short Interest
news
over two weeks ago at news.google.com         
Heres Why Cidara Therapeutics, Inc. Is Skyrocketing - MSN
Google News at Macroaxis
over two weeks ago at news.google.com         
Cidara Therapeutics, Inc. Short Interest Update - MarketBeat
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Heres Why Cidara Therapeutics, Inc. Is Skyrocketing
Yahoo News
over three weeks ago at investing.com         
Cidara Therapeutics announces board changes, CMO separation
Investing News at Macroaxis
over three weeks ago at news.google.com         
Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Les Tari of 150224 shares of Cidara Therapeutics at 10.75 subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.macroaxis.com         
Acquisition by Ra Capital Management, L.p. of 22200 shares of Cidara Therapeutics at 26.62 subject t...
Macroaxis News
over a month ago at news.google.com         
Cidara Therapeutics stock soars to 52-week high of 24.99 - Investing.com
Google News at Macroaxis
over a month ago at seekingalpha.com         
Cidara Therapeutics files to sell 7.04M shares of common stocks by selling shareholders
seekingalpha News
over a month ago at news.google.com         
Cidara Therapeutics Just Flashed Golden Cross Signal Do You Buy - MSN
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Canale-theakston Carin of 16000 shares of Cidara Therapeutics at 22.81 subject to Rul...
Macroaxis News
over a month ago at thelincolnianonline.com         
Short Interest in Cidara Therapeutics, Inc. Expands By 6.0
news
Far too much social signal, news, headlines, and media speculation about Cidara Therapeutics that are available to investors today. That information is available publicly through Cidara media outlets and privately through word of mouth or via Cidara internal channels. However, regardless of the origin, that massive amount of Cidara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cidara Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cidara Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cidara Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cidara Therapeutics alpha.

Cidara Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Cidara Stock Analysis

When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.